Periodic Reporting for period 4 - TransBioLine (Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease)

TransBioLine will generate exploratory and confirmatory data to support the qualification of biomarkers associated with drug-induced organ injury of five different organ systems; kidney (DIKI), liver (DILI), pancreas (DIPI), vascular (DIVI), and central nervous system (DINI);...